Fresh from the pipeline - Rilonacept
Fresh from the pipeline - Rilonacept
复制标题
DOI：
10.1038/nrd2579
复制
发表时间：
2008-05-01
影响因子：
120.1
通讯作者：
Kirkpatrick, Peter
中科院分区：
文献类型：
--
作者：
Hoffman, Hal M.;Yasothan, Uma;Kirkpatrick, Peter
2008年2月，ilonacept (Arcalyst; Regeneron)，一种白细胞介素1阻滞剂，被美国FDA批准用于治疗一组罕见的自身炎症性疾病，称为冷冻素相关周期性综合征。
In February 2008, rilonacept (Arcalyst; Regeneron), an interleukin 1 blocker, was approved by the US FDA for the treatment of a group of rare autoinflammatory diseases known as cryopyrin-associated periodic syndromes.